Replies to post #166045 on Biotech Values

[north40000]

ASTX deal, another view:

....the proposed $8.50 per share offer from Otsuka is wholly inadequate considering the valuable collection of assets Astex has assembled....

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=91720435